According to news on April 25, there are seven major benefits that may affect the stock market tomorrow, specifically: 1. Asia Sky Integration: Net profit in the first quarter was 117 million yuan, a year-on-year increase of 258.14%. Asia Sky Integration (603929) disclosed its first quarter report on the evening of April 25. In the first quarter of 2024, operating income was 1.096 billion yuan, a year-on-year increase of 239.64%; net profit was 117 million yuan, a year-on-year increase of 258.14%. The main reason was the increase in operating income, and the amount of impairment provisions provided for the reversal of early construction project repayments was larger than the previous year. It is caused by a combination of various reasons.
2. Northern Shares: Net profit in the first quarter was 51.9388 million yuan, a year-on-year increase of 151.16%. Northern Shares (600262) disclosed its first quarter report on the evening of April 25. In the first quarter of 2024, it achieved operating income of 828 million yuan, a year-on-year increase of 115.25%; net profit was 5193.88 million, a year-on-year increase of 151.16%.
Sales revenue increased during the reporting period.
3. Hailian Jinhui: It will pay close attention to the application opportunities of lightweight new materials in low-altitude fields and actively expand the product market. Hailian Jinhui stated on the interactive platform on April 25 that the company continues to increase its investment in research and development of lightweight products. , through the New Materials and Lightweight Research Institute to achieve the research and development and implementation of new materials, new technologies, and new products, we will pay close attention to the application opportunities of new lightweight materials in low-altitude fields, and actively expand the product market.
4. Jincheng Pharmaceutical: The marketing application for oseltamivir phosphate chemical raw material drug was approved. Jincheng Pharmaceutical (300233) announced on the evening of April 25 that its wholly-owned subsidiary Jincheng Taier received the oseltamivir phosphate issued by the State Food and Drug Administration. Chemical API marketing application approval notice.
Oseltamivir phosphate is clinically suitable for the treatment of influenza A and B in adults and children aged 1 and over, and the prevention of influenza A and B in adults and adolescents aged 13 and over.
5. Antarctic E-commerce’s revenue and net profit increased in the first quarter Antarctic E-commerce (002127) disclosed its first quarter report on the evening of April 25, achieving revenue of 715 million yuan, a year-on-year increase of 16.99%.
Among them, Time Internet’s revenue was 631 million yuan, and Antarctic e-commerce headquarters’ revenue was 84 million yuan.
The growth in revenue is mainly due to the deepening of Time Internet\’s existing business lines and the development of new business lines. The business scale of the mobile Internet media delivery platform has increased year-on-year. At the same time, with the active expansion of the fashion series authorized services and strategic cooperation authorized service businesses of the Antarctic E-commerce Headquarters, the brand Revenue from licensing and comprehensive services business increased by more than 30% year-on-year.
Net profit was 48 million yuan, a year-on-year increase of 33.92%, mainly due to the growth in the scale of the Antarctic e-commerce brand comprehensive service business.
6. Sichuan Jinnuo: Net profit in the first quarter was 20.379 million yuan, a year-on-year increase of 412.33%. Sichuan Jinnuo (300505) disclosed its first quarter report on the evening of April 25. The company achieved operating income of 581 million yuan in the first quarter of 2024, a year-on-year increase of 11.76%; Net profit was 20.379 million yuan, a year-on-year increase of 412.33%.
7. Jianhui Information: Signed a strategic cooperation agreement with the Russian MEDSNAB Group. Jianhui Information (605186) announced on the evening of April 25 that on April 25, the company signed a written strategic cooperation agreement with the Russian MEDSNAB-GROUP LLC Company (referred to as \”MEDSNAB Group\”). Cooperation Agreement.
As a well-known overall solution provider for medical logistics automation, informatization, intelligence and mobile medical services in China, the company will provide services to the Moscow State Medical and Health Committee and the St. Petersburg State Medical and Health Committee within 3 months based on the actual business needs specified by MEDSNAB Group. Develop new fully automated outpatient medicine dispensing machines, etc. The cooperation period is 5 years.
MEDSNAB Group is a recognized medical equipment supplier in Russia and the CIS countries.
The signing of the strategic cooperation agreement will help accelerate the company\’s overseas expansion strategy, especially in the Russian market.
